Carol Miceli | Director of Investor Relations |
Jay Luly | President & Chief Executive Officer |
Paul Mellett | Chief Financial Officer |
Brian Abrahams | RBC Capital Markets |
Paul O'Brien | Roth Capital |
Eric Joseph | JPMorgan |
Jay Olson | Oppenheimer |
Jack Allen | Baird |
Patrick Trucchio | Berenberg Capital Markets. |
Good afternoon. My name is Jesse, and I will be your conference operator today. At this time, I would like to welcome everyone to the Enanta Pharmaceuticals Second Quarter Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.